ENDRA Life Sciences (NDRA) EPS (Basic): 2016-2024
Historic EPS (Basic) for ENDRA Life Sciences (NDRA) over the last 9 years, with Dec 2024 value amounting to -$21.43.
- ENDRA Life Sciences' EPS (Basic) fell 2331.82% to -$5.35 in Q4 2021 from the same period last year, while for Dec 2021 it was -$5.55, marking a year-over-year decrease of 545.35%. This contributed to the annual value of -$21.43 for FY2024, which is 98.97% up from last year.
- According to the latest figures from FY2024, ENDRA Life Sciences' EPS (Basic) is -$21.43, which was up 98.97% from -$2,082 recorded in FY2023.
- Over the past 5 years, ENDRA Life Sciences' EPS (Basic) peaked at -$0.63 during FY2020, and registered a low of -$2,082 during FY2023.
- Moreover, its 3-year median value for EPS (Basic) was -$21.43 (2024), whereas its average is -$702.81.
- Per our database at Business Quant, ENDRA Life Sciences' EPS (Basic) slumped by 45,567.46% in 2023 and then spiked by 98.97% in 2024.
- Yearly analysis of 5 years shows ENDRA Life Sciences' EPS (Basic) stood at -$0.63 in 2020, then tumbled by 780.95% to -$5.55 in 2021, then grew by 17.84% to -$4.56 in 2022, then slumped by 45,567.46% to -$2,082 in 2023, then skyrocketed by 98.97% to -$21.43 in 2024.